Sign in
4

Changes in Ownership

Celldex Therapeutics, Inc. Filed Acc 0001415889-24-015542

SVP & GENERAL COUNSEL sold 8,006 shares at $33.60 ($269,002)

  • SVP & GENERAL COUNSEL acquired 8,006 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Jimenez Freddy A. SVP & GENERAL COUNSEL 2024-06-03 Option exercise +8,006 $10.38 $83,102 33,930 D
Jimenez Freddy A. SVP & GENERAL COUNSEL 2024-06-03 Sale −8,006 $33.60 $269,002 25,924 D
Derivatives
Jimenez Freddy A. SVP & GENERAL COUNSEL 2024-06-03 Option exercise · Incentive Stock Option (Right to Buy) −8,006 27,994 D
Open-market sales · 8,006 sh · avg $33.60 · $269,002
Loading xslF345X05/form4-06052024_080652.xml…